Mina Kang

St Vincent's Centre For Applied Medical Research
Darlinghurst, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure.

899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure.

Journal: Phlebology
Published: October 30, 2023

Response to - Letter to the editor 'Transparietal diffusion of polidocanol: Potential complication of sclerotherapy?'

Response to - Letter to the editor 'Transparietal diffusion of polidocanol: Potential complication of sclerotherapy?'

Journal: Phlebology
Published: October 11, 2023

Pigmentation of lower limbs: Contribution of haemosiderin and melanin in chronic venous insufficiency and related disorders.

Pigmentation of lower limbs: Contribution of haemosiderin and melanin in chronic venous insufficiency and related disorders.

Journal: Phlebology
Published: August 29, 2023

Sclerotherapy of lower limb veins: Indications, contraindications and treatment strategies to prevent complications - A consensus document of the International Union of Phlebology-2023.

Sclerotherapy of lower limb veins: Indications, contraindications and treatment strategies to prevent complications - A consensus document of the International Union of Phlebology-2023.

Journal: Phlebology
Published: March 14, 2023

Myopericytomatosis: A rare entity mimicking other vascular tumours and malformations.

Myopericytomatosis: A rare entity mimicking other vascular tumours and malformations.

Journal: The Australasian journal of dermatology
Published: December 12, 2022

Skin necrosis following sclerotherapy. Part 2: Risk minimisation and management strategies.

Skin necrosis following sclerotherapy. Part 2: Risk minimisation and management strategies.

Journal: Phlebology
Published: September 16, 2022

Skin necrosis following sclerotherapy. Part 1: Differential diagnosis based on classification of pathogenic mechanisms.

Skin necrosis following sclerotherapy. Part 1: Differential diagnosis based on classification of pathogenic mechanisms.

Journal: Phlebology
Published: May 03, 2022

Treatment of venous malformations with tumescent-assisted sclero-embolic and ablative lasers (SEALs): Safe and effective long-term outcomes.

Treatment of venous malformations with tumescent-assisted sclero-embolic and ablative lasers (SEALs): Safe and effective long-term outcomes.

Journal: Phlebology
Published: March 28, 2022

Treatment of facial hypertrophic capillary malformations with tumescent-assisted sclerotherapy.

Treatment of facial hypertrophic capillary malformations with tumescent-assisted sclerotherapy.

Journal: The Australasian journal of dermatology
Published: February 02, 2022

An analysis of the prevalence of osteoporosis and osteopenia in patients with epidermolysis bullosa: A cross-sectional study.

An analysis of the prevalence of osteoporosis and osteopenia in patients with epidermolysis bullosa: A cross-sectional study.

Journal: Experimental dermatology
Published: May 04, 2020

Deep vein sclerosis following sclerotherapy: Ultrasonic and d-dimer criteria.

Deep vein sclerosis following sclerotherapy: Ultrasonic and d-dimer criteria.

Journal: Phlebology
Published: September 13, 2019

Cyanoacrylate closure for peripheral veins: Consensus document of the Australasian College of Phlebology.

Cyanoacrylate closure for peripheral veins: Consensus document of the Australasian College of Phlebology.

Journal: Phlebology
Published: August 02, 2019
Showing 1-12 of 17

Last Updated: 09/26/2026